For citations:
Artamonova E.V., Kovalenko E.I., Bolotina L.V., Stenina M.B., Orlova R.V., Mukhina M.A. CDK4/6 inhibitors in the treatment of metastatic breast cancer. Choosing optimal therapy for estrogen-receptor-positive HER2-negative metastatic breast cancer: analysis of doctors’ preferences (“Prometheus”) in Russia – first results of the survey. Tumors of female reproductive system. 2020;16(3):37-45. (In Russ.) https://doi.org/10.17650/1994-4098-2020-16-3-37-45
Email this article 